Rhea-AI Summary
Windward Bio Group (WWB) priced its initial public offering of common shares at $17.00 per share, alongside a concurrent private placement. The IPO comprises 10,294,117 common shares, all offered by Windward. Combined gross proceeds are expected to be $225.0 million, before fees and expenses and excluding the underwriters’ option.
Sanofi Foreign Participations will purchase 1,532,691 common shares and pre-funded warrants to purchase 1,408,485 common shares for $50.0 million. Underwriters have a 30-day option to purchase up to 1,544,117 additional shares. Trading on the Nasdaq Global Select Market is expected to begin November 13, 2026. The IPO is expected to close November 16, 2026, when the private placement is also scheduled to close.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags